DIAGNOS (CVE:ADK) Shares Up 6.1% – Still a Buy?

DIAGNOS Inc. (CVE:ADK)’s stock price traded up 6.1% during mid-day trading on Tuesday . The company traded as high as C$0.35 and last traded at C$0.35. 366,651 shares traded hands during trading, an increase of 62% from the average session volume of 225,865 shares. The stock had previously closed at C$0.33.

DIAGNOS Trading Up 6.1%

The stock has a market capitalization of C$35.65 million, a P/E ratio of -7.00 and a beta of -0.50. The company has a debt-to-equity ratio of -355.56, a quick ratio of 0.68 and a current ratio of 1.09. The firm’s fifty day simple moving average is C$0.32 and its 200 day simple moving average is C$0.28.

DIAGNOS Company Profile

DIAGNOS Inc provides software-based services primarily in Canada, the United States, Colombia, Spain, Mexico, Saudi Arabia, and Costa Rica. The company offers healthcare services through Computer Assisted Retina Analysis, a web-based software tool that assists healthcare professionals for the detection of diabetic retinopathy; and allows eye care specialist to visualize both normal retinal landmarks and pathological changes. It also provides various consulting services in the fields of data analysis and artificial intelligence.